Hear Dr. Traber speak at 2nd Annual H.C. Wainwright NASH Investor Conference, March 19, 2018 @ 4:00 pm ETMarch 16, 2018 | Presentation
Listen to Dr. Traber present at CHIPS, in Hangzhou, China. March 17, 2018 @ 8:30 am China Standard TimeMarch 16, 2018 | Presentation
A general overview of the company's activities and Clinical Phase studies with the Galectin-3 inhibitor GR-MD-02.
A detailed review of the results of the NASH-CX Clinical Trial.
A detailed review of the use of GR-MD-02 in combination therapy with KEYTRUDA in advanced melanoma.